TXG DCF Valuation - 10X Genomics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 42.73 USD -0.86% Market Closed

Market Cap: $5.4B

	10X Genomics Inc NASDAQ:TXG	US
T	Takeda Pharmaceutical Co Ltd OTC:TKPHF	JP
	SOL SpA MIL:SOL	IT
U	Uniqa Insurance Group AG VSE:UQA	AT
3	3i Group PLC F:IGQ5	UK
C	China Oilfield Services Ltd XMUN:CO9	CN
S	Starbucks Corp XBER:SRB	US
B	Barclays PLC XBER:BCY	UK
I	Imperial Oil Ltd AMEX:IMO	CA
	Ligand Pharmaceuticals Inc NASDAQ:LGND	US
S	Sirius XM Holdings Inc DUS:RDO	US

TXG's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue TXG Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

F • EUR

1KJ

LSE • USD

0A88

Join 347,400+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.